Lv6
2990 积分 2022-11-23 加入
Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression
2个月前
已完结
A First-in-Class STAT3 Degrader KT-333 in Development for Treatment of Hematologic Cancers
2个月前
已完结
A First-in-Class STAT3 Degrader KT-333 in Development for Treatment of Hematologic Cancers
3个月前
已完结
Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor
3个月前
已完结
Targeting STAT3 in Cancer Immunotherapy
4个月前
已完结
The molecular regulation of Janus kinase (JAK) activation
4个月前
已完结
Broussonin E suppresses LPS-induced inflammatory response in macrophages via inhibiting MAPK pathway and enhancing JAK2-STAT3 pathway
4个月前
已完结
Resokaempferol-mediated anti-inflammatory effects on activated macrophages via the inhibition of JAK2/STAT3, NF-κB and JNK/p38 MAPK signaling pathways
4个月前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
4个月前
已完结
Targeting the Stat6 pathway in tumor‐associated macrophages reduces tumor growth and metastatic niche formation in breast cancer
5个月前
已完结
皖公网安备34019202002308
